• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载一线抗结核药物的淀粉纳米晶用于抗击 H37Rv 结核分枝杆菌菌株的威胁。

First-line anti-tubercutilosis drugs-loaded starch nanocrystals for combating the threat of M. tuberculosis H37Rv strain.

机构信息

School of Chemical Sciences, Central University of Gujarat, Gandhinagar, 382030, India.

School of Chemical Sciences, Central University of Gujarat, Gandhinagar, 382030, India.

出版信息

Carbohydr Res. 2020 Sep;495:108070. doi: 10.1016/j.carres.2020.108070. Epub 2020 Jun 27.

DOI:10.1016/j.carres.2020.108070
PMID:32634645
Abstract

Nanoparticles-based drug delivery is at the forefront in the field of pharmaceutical and medicinal research to eradicate or alleviate the associated impediments, such as prolonged treatment time, high doses, toxicity and resistance problem of anti-tuberculosis drugs for the treatment of age-old tuberculosis disease. Herein, the first-line anti-tuberculosis drugs were loaded into the biodegradable starch nanocrystals and native starch to improve the therapeutic profile addressing the existing issues related to conventional drugs. The loading performance of anti-tuberculosis drugs with starch nanocrystals and native starch was found in the range of 65-95%. According to the release study, the native starch was not appropriate, however, the starch nanocrystals demonstrated sustained release drug delivery for isoniazid and pyrazinamide ranging from 50 to 93% for 24 h; the burst release for streptomycin was reported at pH 2 in 6.5 h while only 14% rifampicin was released at pH 8 buffer. An anti-mycobacterium analysis of strain H37Rv showed that minimum inhibition concentration of starch nanocrystals loaded with isoniazid and pyrazinamide (0.033 μg/mL and 1.25 μg/mL, respectively) were more effective than the parent isoniazid (0.2 μg/mL) and pyrazinamide (25.0 μg/mL) at pH 5.5.

摘要

基于纳米粒子的药物输送是药物和医学研究领域的前沿技术,旨在消除或减轻相关障碍,如延长治疗时间、高剂量、抗结核药物的毒性和耐药性问题,以治疗古老的结核病。在此,将一线抗结核药物载入可生物降解的淀粉纳米晶和天然淀粉中,以改善治疗效果,解决与传统药物相关的现有问题。研究发现,淀粉纳米晶和天然淀粉对抗结核药物的载药性能在 65-95%范围内。根据释放研究,天然淀粉并不合适,但淀粉纳米晶对异烟肼和吡嗪酰胺的药物释放表现出持续释放的特点,在 24 小时内释放 50-93%;链霉素在 pH 2 时在 6.5 小时内快速释放,而 rifampicin 仅在 pH 8 缓冲液中释放 14%。对 H37Rv 菌株的抗分枝杆菌分析表明,载有异烟肼和吡嗪酰胺的淀粉纳米晶的最低抑菌浓度(分别为 0.033μg/mL 和 1.25μg/mL)比原药异烟肼(0.2μg/mL)和吡嗪酰胺(25.0μg/mL)在 pH 5.5 时更有效。

相似文献

1
First-line anti-tubercutilosis drugs-loaded starch nanocrystals for combating the threat of M. tuberculosis H37Rv strain.载一线抗结核药物的淀粉纳米晶用于抗击 H37Rv 结核分枝杆菌菌株的威胁。
Carbohydr Res. 2020 Sep;495:108070. doi: 10.1016/j.carres.2020.108070. Epub 2020 Jun 27.
2
Polyurethane-functionalized starch nanocrystals as anti-tuberculosis drug carrier.聚氨酯功能化淀粉纳米晶作为抗结核药物载体。
Sci Rep. 2021 Apr 15;11(1):8331. doi: 10.1038/s41598-021-86767-1.
3
Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against H37Rv strain.利福平与异烟肼苯腙在可生物降解聚合物纳米粒中抗 H37Rv 株的抗分枝杆菌药敏试验评价。
Int J Nanomedicine. 2018 Jul 23;13:4303-4318. doi: 10.2147/IJN.S163925. eCollection 2018.
4
Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India.印度古吉拉特邦的原发性耐结核病及获得性利福平耐药情况。
Tubercle. 1988 Mar;69(1):37-42. doi: 10.1016/0041-3879(88)90038-4.
5
Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.耐多药、单耐药和药物敏感结核分枝杆菌的分泌蛋白谱分析
Arch Microbiol. 2018 Mar;200(2):299-309. doi: 10.1007/s00203-017-1448-0. Epub 2017 Nov 8.
6
Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.链霉素、异烟肼、利福平、乙胺丁醇和吡嗪酰胺单独及联合使用对结核分枝杆菌的杀菌活性。
Am Rev Respir Dis. 1977 Oct;116(4):627-35. doi: 10.1164/arrd.1977.116.4.627.
7
Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.沙特阿拉伯结核分枝杆菌对抗结核药物的耐药性不断增加。
Int J Antimicrob Agents. 2001 May;17(5):415-8. doi: 10.1016/s0924-8579(01)00298-9.
8
[Antimicrobial resistance in tuberculosis].[结核病中的抗菌药物耐药性]
Rev Esp Quimioter. 2013 Dec;26(4):332-6.
9
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.结核分枝杆菌对异烟肼、利福平及吡嗪酰胺耐药性的分子基础
Respir Res. 2001;2(3):164-8. doi: 10.1186/rr54. Epub 2001 Apr 5.
10
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.一类新型异烟酰腙单独及与异烟肼、利福平、乙胺丁醇、对氨基水杨酸和氯法齐明联合使用对结核分枝杆菌的活性。
J Antimicrob Chemother. 2002 Feb;49(2):275-82. doi: 10.1093/jac/49.2.275.

引用本文的文献

1
Progress and Principle of Drug Nanocrystals for Tumor Targeted Delivery.药物纳米晶用于肿瘤靶向递药的进展与原理。
AAPS PharmSciTech. 2021 Dec 28;23(1):41. doi: 10.1208/s12249-021-02200-w.
2
An Efficient Approach to Prepare Water-Redispersible Starch Nanocrystals from Waxy Potato Starch.一种从蜡质马铃薯淀粉制备水分散性淀粉纳米晶体的有效方法。
Polymers (Basel). 2021 Jan 29;13(3):431. doi: 10.3390/polym13030431.